NCT07877220Not yet recruiting
Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image Registration
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
The goal of this research study is to find out if using an updated version of standard computer software (called RayStation) for confirming that thermal ablation treatment was able to destroy all tumor cells including a safety margin.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 14 Oct 2026
- Start date
- 1 Apr 2027
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07877220
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 1 Apr 2027 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \<18 years old
Other
- Currently breastfeeding or pregnant
- Unable to receive at least pre- and final post-ablation contrast-enhanced CT during the ablation procedure
Who the study is looking for
- Patients with primary or secondary liver tumors referred for percutaneous thermal liver ablation as per the standard of care
- ≤5 abatable tumors
- Each tumor measuring ≤5 cm in its largest dimension
- Ability to obtain a 5 mm MAM on pre- and intraprocedural CECT
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UT MD Anderson Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.